Dublin, Sept. 24, 2021 (GLOBE NEWSWIRE) -- The "India Post COVID Health Tests Market, FY2027" report has been added to ResearchAndMarkets.com's offering.
India post COVID health tests market is anticipated to grow with an impressive CAGR in the forecast period, FY2023-FY2027
The market is expected to grow at double digit annual growth rate on the account of growing need of early and effective diagnostic process along with to identify any adverse effects of COVID infection. The widespread infection that was termed as a pandemic soon enough by World Health Organization has already claimed millions of lives worldwide.
In India alone the virus has claimed more than 423 thousand lives and the medical authorities are claiming that a third wave of infection is soon due in few months. The recovery rate from the viral infection has improved in the past months though dangers of after-effects of the infection, vaccination, and pre vaccination concerns for CRP (c-reaction protein) is actively driving the growth of the market in the subsequent five years.
Moreover, a part of population already suffering from kidney and liver disorders and related diseases are expected to go through series of health tests and get clearance from doctors and health advisors to get vaccinated, the factor is a major factor responsible for the growth of India post COVID health tests market in the upcoming five years, until FY2027.
The India post COVID health tests market is segmented by type of test, provider type, end user, regional distribution, top 3 states analysis, and competitional landscape. Based on type of test, the market is further bifurcated into COVID-19 IgG antibody test, hematology, biochemistry urea & electrolytes, liver function tests, kidney function tests, and others.
COVID-19 IgG antibody test is anticipated to register fastest growing CAGR in the upcoming five years on the account of surge in the demand for the COVID-19 IgG antibodies in the patients that have already recovered from the infection. COVID-19 Immunoglobulin G antibodies are the immunoglobulin antibody proteins that are responsible for overcoming the COVID-19 viral infection.
With the help of self-sufficient immune system of the body, these immunoglobulin antibodies are generated and help in protection against the coronavirus. In some cases, the antibodies do not develop and the patient suffering from the viral infection requires artificial transfer of the plasma that contains higher concentration of the COVID-19 IgG and thus the test is required to collect the blood plasma samples and thus aiding the growth of the market.